We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Tools Devised for Earlier Breast Cancer Diagnosis

By HospiMedica International staff writers
Posted on 01 Jul 2010
Advanced techniques for investigating suspected breast cancer are now complementing traditional mammography. More...
A team of European and U.S. researchers is developing ways to combine all these data to help physicians make earlier and more accurate diagnoses.

As the causes of breast cancer are not well understood, the priority is to detect it early so that effective treatment can be given. The earlier the cancer is detected the more likely the treatment is to be successful. Many countries now employ X-ray mammography screening for women over 40 or 50, but cases still go undetected because of the difficulty of making an accurate diagnosis. Even with a mammogram, some cancers will be unnoticed and there will be many cases of false positives that require further investigation. Validation is typically made by ultrasound and biopsy but many biopsies will show that a suspected lump is not cancerous.

"From mammography you can't always really see if there is something serious or if it's just something that is not cancer,” said Dr. Sonja Guttenbrunner of the European Institute for Biomedical Imaging (Vienna, Austria). "Sometimes it's very difficult to detect breast cancer and often unnecessary biopsies are taken.”

Even if cancer is confirmed, some types will never pose a risk to health but they cannot easily be differentiated from tumors that are likely to spread. The result is that many women undergo surgery, radiotherapy, and chemotherapy that would not have been necessary if a more precise diagnosis were possible.

Other diagnostic tools, such as ultrasound, are typically used as a follow-up to mammography. Newer techniques include X-ray tomosynthesis, magnetic resonance imaging (MRI), positron emission mammography (PEM), and automated three-dimensional (3D) ultrasound. All these techniques reveal diverse data about any suspicious lump and together they can help the clinician make a more informed and accurate diagnosis.

But what is the best way to use all these sources of information? That is where the European Union (EU)-funded HAMAM Project (Vienna, Austria) comes in. The HAMAM (Highly Accurate Breast Cancer Diagnosis through Integration of Biological Knowledge, Novel Imaging Modalities, and Modeling) is developing a tool that will be more accurate in the diagnosis of breast cancer and be able to integrate all these different modalities in one clinical workstation, suggests Dr. Guttenbrunner, who is coordinating the project.

The clinicians will be able to compare different images side by side while viewing the patient's history and other information. HAMAM also aims to help clinicians with an element of computer-assisted diagnosis. The workstation will be connected to an extensive database of images and other clinical data. It will be able to suggest further investigations to guide the doctor in coming to a diagnosis.

The project has a prototype workstation that is being evaluated in preparation for a public demonstration. A prototype database is available and the clinical partners have supplied anonymized patient information.

Clinical partners in the project include hospitals in Berlin (Germany), Dundee (UK), Nijmegen (The Netherlands), and a partner in the United States. Boca Raton Community Hospital (FL, USA) was chosen for their experience in using multimodal imaging in the diagnosis of breast cancer. They are supplying much of the information that is being used to construct the database.

"Breast cancer is a worldwide issue, both epidemiologically and economically, but handled differently in Europe than in the U.S.,” Dr. Guttenbrunner added. "Therefore, joint research is a good way to combine the different perspectives.” They are supported by technological partners in London [UK], Bremen [Germany], Nijmegen, and Zurich [Switzerland]. "At the end of the project, we want to have a workstation that can be brought to the market,” she said. "We have an industrial partner, Mevis Medical Solutions [Bremen], who will further develop the workstation to actually bring it to the market for clinicians.”

HAMAM builds on two earlier EU-funded projects, SCREEN and SCREEN-TRIAL, which developed approaches to reading mammograms from a digital display screen rather than from traditional X-ray films.

Related Links:
European Institute for Biomedical Imaging
HAMAM Project


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Desk Aneroid Sphyg
Diagnostix 750D+
Digital Radiography System (Ceiling Free)
Digix CF Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Coredio’s CPSE is a a software-as-a-medical-device platform designed for use with consumer smartwatches and standard blood pressure cuffs in clinical and home settings under physician supervision (Photo courtesy of Coredio)

AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure

Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.